Literature DB >> 4113225

HL-A antigens and multiple sclerosis.

C Jersild, A Svejgaard, T Fog.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4113225     DOI： 10.1016/s0140-6736(72)90962-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  75 in total

1.  Reviewing multiple sclerosis.

Authors:  A Compston
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

2.  Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additive.

Authors:  Maartje Boon; Ilja M Nolte; Jacques De Keyser; Charles H C M Buys; Gerard J te Meerman
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

3.  Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis.

Authors:  Justin P Rubio; Melanie Bahlo; Niall Tubridy; Jim Stankovich; Rachel Burfoot; Helmut Butzkueven; Caron Chapman; Laura Johnson; Mark Marriott; Grant Mraz; Brian Tait; Chris Wilkinson; Bruce Taylor; Terence P Speed; Simon J Foote; Trevor J Kilpatrick
Journal:  Hum Genet       Date:  2004-03-11       Impact factor: 4.132

4.  Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis.

Authors:  Marie-Claude Babron; Hervé Perdry; Adam E Handel; Sreeram V Ramagopalan; Vincent Damotte; Bertrand Fontaine; Bertram Müller-Myhsok; George C Ebers; Françoise Clerget-Darpoux
Journal:  Eur J Hum Genet       Date:  2011-11-16       Impact factor: 4.246

Review 5.  [The genetic profile of multiple sclerosis: risk genes and the "dark matter"].

Authors:  C M Lill; F Zipp
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

Review 6.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

7.  A high-density screen for linkage in multiple sclerosis.

Authors:  Stephen Sawcer; Maria Ban; Mel Maranian; Tai Wai Yeo; Alastair Compston; Andrew Kirby; Mark J Daly; Philip L De Jager; Emily Walsh; Eric S Lander; John D Rioux; David A Hafler; Adrian Ivinson; Jacqueline Rimmler; Simon G Gregory; Silke Schmidt; Margaret A Pericak-Vance; Eva Akesson; Jan Hillert; Pameli Datta; Annette Oturai; Lars P Ryder; Hanne F Harbo; Anne Spurkland; Kjell-Morten Myhr; Mikko Laaksonen; David Booth; Robert Heard; Graeme Stewart; Robin Lincoln; Lisa F Barcellos; Stephen L Hauser; Jorge R Oksenberg; Shannon J Kenealy; Jonathan L Haines
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

8.  Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.

Authors:  Justin P Rubio; Melanie Bahlo; Jim Stankovich; Rachel K Burfoot; Laura J Johnson; Stewart Huxtable; Helmut Butzkueven; Ling Lin; Bruce V Taylor; Terence P Speed; Trevor J Kilpatrick; Emmanuel Mignot; Simon J Foote
Journal:  Immunogenetics       Date:  2007-01-26       Impact factor: 2.846

9.  An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.

Authors:  G C DeLuca; S V Ramagopalan; B M Herrera; D A Dyment; M R Lincoln; A Montpetit; M Pugliatti; M C N Barnardo; N J Risch; A D Sadovnick; M Chao; S Sotgiu; T J Hudson; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

Review 10.  From genes to function: the next challenge to understanding multiple sclerosis.

Authors:  Lars Fugger; Manuel A Friese; John I Bell
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.